Immunodeficiencies

Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders

Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV

Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC

V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency

Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies

Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC

CHP 834 Unrelated and Partially Matched Related Donor Peripheral Stem Cell Transportation for T and B Cell Depletion

COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations

Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation

Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases

Novel Testing Procedures

Unrelated Donor Transplant for Malignant and Non-Malignant Disorders

Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders